Plain-English translation of NCT06735612 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is examining how often a virus called respiratory syncytial virus (RSV) is present when adults with chronic obstructive pulmonary disease (COPD) experience sudden flare-ups of their breathing symptoms. Researchers want to understand whether having RSV during these flare-ups leads to worse outcomes — such as longer hospital stays, more serious heart problems, or other complications — compared to flare-ups without the virus.
COPD causes serious breathing problems, and flare-ups can be life-threatening. This study exists because doctors need to better understand whether RSV infections make these flare-ups worse and whether patients with the virus need different treatment or closer monitoring. Right now, there is not enough clear information about how common RSV is during COPD flare-ups or how much it affects patient outcomes.
You likely qualify if…
You likely don't qualify if…
When you come to the emergency department or day hospital for a COPD flare-up, the research team will ask you to be part of this study. You will receive your normal medical treatment for the flare-up. As part of routine care, you'll have standard testing done to check for RSV infection. The team will collect basic information about your health history and track what happens to you during and after this flare-up — including whether you are hospitalized, how long you stay in the hospital, and any heart-related problems that develop. This is not a medication study; researchers are simply observing and learning from your experience.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Spain